Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)
Event:
ESC Congress 2023
Topic:
Epidemiology, Prognosis, Outcome
Session:
Prognosis and outcome in patients with atrial fibrillation